Kumar Yadav Amit, Rusia Usha
Department of Pathology, University College of Medical Sciences, Dilshad Garden 110095 New Delhi, India, Phone: 011-22586262 E-mail:
Turk J Haematol. 2010 Sep 5;27(3):200-3. doi: 10.5152/tjh.2010.29.
HbQ-India is a rare alpha chain variant that usually presents in the heterozygous state. Normally, HbQ-India is clinically silent. It becomes symptomatic when present in association with other conditions. We report a case of HbQ-India with concomitant presence of iron deficiency anemia. A 16-year-old female presented with weakness and pallor intermittently for six years. Complete blood count showed severe microcytic hypochromic anemia. Hemoglobin electrophoresis showed a prominent band in the S,D,G region. Tests for sickling were negative. High performance liquid chromatography (HPLC) showed a peak in the unknown window (4.70-4.90 min) suggestive of HbQ-India. Serum iron profile was suggestive of iron deficiency anemia. Based on the above findings, a diagnosis of coexistent HbQ-India-iron deficiency anemia was made. A family study revealed the father as having moderate anemia with similar findings while the mother was normal. Abnormal hemoglobin in the patient was confirmed by molecular diagnosis. HbQ variants are the alpha globin chain variants due to structural mutations (α64 Asp→His) inherited in autosomal dominant fashion. Three molecular variant types have been documented, namely HbQ-India, HbQ-Thailand and HbQ-Iran. Normally, HbQ is clinically silent. Therefore, careful screening of the samples using routine techniques like Hb electrophoresis and HPLC are needed for identification of such abnormal hemoglobin variants like HbQ-India.
印度血红蛋白Q是一种罕见的α链变体,通常以杂合状态出现。正常情况下,印度血红蛋白Q在临床上无明显症状。当与其他病症同时存在时会出现症状。我们报告一例伴有缺铁性贫血的印度血红蛋白Q病例。一名16岁女性间歇性出现乏力和面色苍白症状达六年。全血细胞计数显示严重的小细胞低色素性贫血。血红蛋白电泳显示在S、D、G区域有一条明显的条带。镰状细胞检测为阴性。高效液相色谱法(HPLC)显示在未知窗口(4.70 - 4.90分钟)有一个峰,提示为印度血红蛋白Q。血清铁指标提示缺铁性贫血。基于上述发现,诊断为印度血红蛋白Q与缺铁性贫血并存。家族研究显示父亲有中度贫血且有类似表现,而母亲正常。通过分子诊断证实了患者存在异常血红蛋白。血红蛋白Q变体是由于结构突变(α64天冬氨酸→组氨酸)导致的α珠蛋白链变体,以常染色体显性方式遗传。已记录有三种分子变体类型,即印度血红蛋白Q、泰国血红蛋白Q和伊朗血红蛋白Q。正常情况下,血红蛋白Q在临床上无明显症状。因此,需要使用血红蛋白电泳和高效液相色谱法等常规技术仔细筛查样本,以识别像印度血红蛋白Q这样的异常血红蛋白变体。